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A total of 21 squamous-cell carcinoma of the conjunctiva (SCC) and 22 control subjects had conjunctival samples tested for human
papillomavirus (HPV) types using PCR-based assays. Epidermodysplasia verruciformis HPV types were found in 86% of SCC cases and
36% of control subjects (Odds ratio¼12.0), suggesting a role of HPVs in the aetiology of SCC.
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Squamous-cell carcinoma of the eye conjunctiva (SCC) is a rare
tumour associated with heavy sun exposure, which has greatly
increased in some Sub-Saharan African countries, coincident with
the spread of HIV (Newton, 1996). An increased risk of SCC has
been reported in HIV-positive individuals in the United States
(Goedert and Cote, 1995). The link with immune impairment
suggests that infectious agents such as epithelio-tropic human
papillomaviruses (HPVs) may be involved in the aetiology of SCC.
HPVs comprise mucosal and cutaneous types, the latter being
found in skin carcinomas from patients with Epidermodysplasia
verruciformis (EV) (zur Hausen, 2000). A subgroup of high-risk
mucosal HPV types, notably HPV 16, 18 and 45, are the cause of
cervical carcinoma and of a subset of ano-genital and head and
neck carcinomas (zur Hausen, 2000). Low-risk HPV types 6 and 11
have been detected in benign papillomas of the conjunctiva, while
studies of SCC have produced inconsistent results. A few studies
found HPV types 16 and 18 DNA in SCC tissue biopsies, while
others did not (Newton, 1996). Squamous-cell carcinoma of the
conjunctiva risk was not associated with antibodies against
HPV16, 18 and 45 in a case–control study in Uganda (Newton
et al, 2002).
METHODS
Between March 2000 and January 2001, we conducted a pilot
case–control study on 21 SCC cases (mean age: 33.5, range 23–49)
and 22 age frequency-matched control patients with benign
conjunctival lesions (mean age 33.8, range 14–55) in New Mulago
Eye Department, Kampala, Uganda, where SCC has become the
most common ocular malignancy. This aimed to assess the
feasibility of a larger case–control study in that location, and to
test methods.
All patients signed an informed consent and the study was
approved by the local Ethical Committee. In total, 10 controls had
pterygium, seven pingueculum, four solar keratosis and one
pigmented naevus. Tissue specimens from SCC cases and control
patients were collected, histologically confirmed, and deep-frozen
before shipment to the International Agency for Research on
Cancer (IARC), Lyon, France, for HPV testing. To minimise the
risk of contamination, the collection of the specimens was
performed at different days using disposable material. DNA was
extracted from each sample in an IARC laboratory that is
exclusively used for this purpose. To monitor the possible
occurrence of cross contamination between the different speci-
mens during the extraction of DNA, tubes containing distilled
water (one every 10 specimens) were included.
HPV detection was performed by means of polymerase chain
reaction (PCR) assays using different sets of primers (Chen et al,
1994; Berkhout et al, 1995; Jacobs et al, 1995; Forslund et al, 1999,
Harwood et al, 1999; Caldeira et al, 2003). Laboratory personnel
were blinded to the histological diagnosis of each patient.
The PCR mixture was prepared in a special laboratory (pre-PCR
laboratory) in sterile conditions, while the PCR and analysis of
products were performed in different laboratories. As in the DNA
extraction protocol, negative controls were included in the
different PCRs. Products obtained with all type-specific primers
were also tested by Southern blotting. All analyses, including
cellular DNA extraction, PCR, and Southern blotting, were
performed in duplicate using consecutive sections of frozen
specimens.
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We first determined the presence of the mucosal HPV types using
the general primers (GP) 5þ/6þ, GP1/GP2 and specific primers
for HPV16, HPV18 and HPV45. No mucosal types were found in
either cases or controls, but in one SCC case (patient number 21)
we detected, by means of GP1/GP2 primers, a novel HPV type
closely related to EV HPV type RTRX7 (Table 1). To search for
other EV HPV types, we used the FAP59/64 primers, which were
designed from two relatively conserved regions present in the L1
gene of most HPV types, including the cutaneous ones. The low-
risk mucosal HPV type 11 was detected in two controls with
pterygium (patient numbers 22 and 23; Table 1).
We then followed three highly sensitive nested PCR protocols
for detecting EV HPV types: CP62/69-EN3F/EN3R; CP62/69-EN1F/
EN1R; and CP66/CP69-CP65/CP70 (Berkhout et al, 1995; Harwood
et al, 1999). We found additional EV HPV types in six cases
(patient numbers 3, 4, 6, 7, 14, 18) and one control (patient
number 43). In the majority of the HPV positive subjects (patient
numbers 3, 4, 7, 18 and 43) we were able to directly sequence the
PCR product and identify the HPV type, including one each for
HPV5, HPV14, HPV24, HPV36, HPV37 and HPV38, in addition to
two novel types closely related to HPV8 and HPV12. In two cancer
cases (patient numbers 3 and 18) and in one control (patient
number 43) we detected multiple HPV infections using these
nested PCR protocols (Table 1). The SCC patients positive for HPV
24 (patient number 4) and HPV 36 and 37 (patient number 18)
were also positive with the protocol CP65/CP70–CP66/CP69, but
we were not able to sequence the PCR products and identify the
specific HPV type(s) involved.
Finally, we performed a PCR analysis followed by Southern
blotting using specific primers for the EV HPV type 38 that we
have used in a previous study on nonmelanoma skin cancer
(Caldeira et al, 2003). These primers are approximately 50–100
fold more sensitive than the CP primers described above in
detecting HPV38 (data not shown). HPV38 E6 specific PCR
followed by Southern blotting showed a positive signal in 17 SCC
cases and eight controls. Only in two SCC cases (patient numbers 4
and 6) and one control (patient number 24) were we able to
demonstrate the presence of HPV38 by DNA sequencing. One case
(patient number 4) was positive for both HPV 38 and HPV 24.
Positive signals at Southern blotting, not confirmed by DNA
sequencing, are likely to correspond to the presence of HPV types
closely related to HPV38 (Table 1). Testing for HPV22 and HPV23,
which are closely related to HPV38, and HPV10, that is associated
with benign skin lesions, gave negative results for all patients. The
results of the different PCR protocols used in the study are
summarised in the last column of Table 1. Overall, EV HPV types
were found in 18 out of 21 (86%) SCC cases and in eight out of 22
(36%) controls.
SCC cases and 20 controls who had a questionnaire including
sociodemographic and lifestyle information are compared in
Table 2 by means of age-adjusted odds ratios (OR) and
corresponding 95% confidence intervals (CI). The OR for the
presence of EV HPV was 12.0 (95% CI: 1.7–84.9). The prevalence
of EV HPV did not vary by age group in either cases or controls.
Educational level was inversely associated with SCC risk, whereas
outdoor occupation and sun exposure were directly associated. On
account of the small number of study patients, the corresponding
confidence intervals were broad and included unity, except for EV
Table 1 Detection of DNA of HPV in biopsies from 21 cases of carcinoma of the conjunctiva and 22 control patients. Kampala, Uganda, 2000–2001
PCR primers
a
Type of lesion
(patient
identification
number) Age GP1/GP2
FAP59/
FAP64 CP62/69 EN3F/EN3R
CP62/69
EN1F/EN1R
CP65/CP70
CP66/CP69 HPV38 E6
Summary
results of EV
HPV positive
b
Carcinoma (1, 5, 8, 9,
10, 11, 12, 13, 16, 19,
20)
25; 30; 26;
42; 34; 24;
30; 39; 48;
30; 43
         ++
Carcinoma (2, 15, 17) 30; 23; 35            
Carcinoma (3) 25    HPV12 related
c HPV8 related
c   ++
Carcinoma (4) 39      HPV24
c + HPV38
c +
Carcinoma in situ (6) 29        + HPV38
c +
Carcinoma (7) 29      HPV14
c   ++
Carcinoma (14) 49        ++ +
Carcinoma (18) 37    HPV37
c HPV36
c ++ +
Carcinoma (21) 36 RTRX7
related
c
        +
Pterygium (22) 33   HPV11
c      ++
Pterigium (23) 19   HPV11
c        
Pterygium (24) 45          HPV38
c +
Pterygium (25, 27, 28,
29, 30)
48; 37; 50;
29; 33
           
Pingueculum
(32, 33, 36, 37, 38) 27; 48; 28;
27; 30
           
Pterygium (26, 31) 29; 26          ++
Pingueculum (34, 35) NA; 32          ++
Solar keratosis (39, 41;
42)
40; NA; 25            
Solar keratosis (40) 55          ++
Pigmented naevi (43) 14      HPV5
c HPV38
c ++
aThe PCR data obtained with GP5+/GP6+, HPV10, HPV16, HPV18, HPV20, HPV22, HPV23 and HPV45 primers were not included in the table since no positive cases were
detected.
bPositive sign indicates that HPV was detected in any of previous columns in the table.
cThe HPV type was determined by direct DNA sequence of the PCR product.
NA¼not available.
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(OR¼22.7) by adjustment for sun exposure (Table 2). We
repeated all analysis in Table 2 excluding from the control group
the three patients with solar keratosis from whom a questionnaire
was available. These lesions have been suggested to be premalig-
nant lesions and may dilute the associations studied. The results
obtained were not materially different from the results presented
in Table 2 (e.g. OR for EV HPV DNA after exclusion of solar
keratosis¼21.8; 95% CI¼1.4–344).
DISCUSSION
The most severe limitation of our findings is that HIV serology was
not available for our study patients. Although medical records did
not mention AIDS, it is likely that a few controls but a majority of
our SCC cases were HIV-positive, as found in a previous study in
Uganda (Newton et al, 2002). We cannot, therefore, rule out the
possibility that immunosuppression due to HIV infection may
partly or even totally explain the strong association between EV
HPV and SCC in this study.
We detected in SCC cases eight different EV HPV types (HPV8,
HPV12, HPV14, HPV24, HPV36, HPV37, HPV38 and RTRX7) in
addition to several undetermined EV HPV types related to HPV38.
HPV38 displays in vitro transforming properties and has been
found in nonmelanomatous skin cancer (Caldeira et al, 2003). In
three SCC cases two different EV HPV types were detected. The
prevalence of EV types was significantly greater among SCC cases
than among controls, although the impact of HIV infection on this
finding is unknown.
The extreme heterogeneity of the cutaneous HPV family and the
lack of standard GP for their detection greatly complicate the study
of the relationship between the cutaneous HPV types and cancers
like SCC. However, the strong association that we found between
EV HPV types and SCC points to a possible aetiological role of
these viruses.
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Table 2 ORs and corresponding 95% CIs of carcinoma of the conjunctiva by presence of EV HPV DNA among 21 cases and 20 controls, Kampala,
Uganda, 2000–2001
Cancer cases Controls OR
a (95% CI) OR
b (95% CI)
HPV DNA
Absent 3 13 1 1
Present 18 7 12.0 (1.7–84.9) 22.7 (1.7–312)
Education
Primary or less 17 8 1
Secondary 4 12 0.3 (0.06–1.1)
Occupation
c
Indoor 5 13 1
Outdoor 15 6 3.2 (0.7–13.8)
Sun exposure (daily hours)
c
o61 0 1 7 1 1
47 11 2 6.4. (0.8–54.2) 29.0 (0.7–1137)
aAdjusted for age and gender by means of Mantel–Haenszel procedure.
bAdjusted for EV HPV DNA or sun exposure, as appropriate.
cSome figures do not add up to the total
because of missing values. EV HPV¼Epidermodysplasia verruciformis (EV) types of human papillomavirus (HPV).
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